Levamisole: Clinical Trials

10 trials of Levamisole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 5 unknown. 10 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Completed 5, Unknown 5
Phase 33Unknown 2, Completed 1

Follow Levamisole: new trials by email Literature Review of Levamisole trials Research Report on Levamisole

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects
Levamisole 3 days, Levamisole 5 days, Placebo - Loiasis
Phase 2 / Phase 3UnknownProgramme National de Lutte contre l'Onchocercose, Republic of the Congo992024-06-212024-09-20
Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
LEV 1 mg/kg, LEV 1,5 mg/kg, LEV 2,5 mg/kg - Onchocerciasis, Ocular, Loiasis
Phase 2CompletedProgramme National de Lutte contre l'Onchocercose, Republic of the Congo2552021-01-162021-09-20
Pharmacological Modulation of Hippocampal Activity in Psychosis 2
Levetiracetam (LEV) 500 mg, Placebo - Schizophrenia; Psychosis
Phase 2CompletedVanderbilt University Medical Center622020-09-232024-02-05
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19
Levamisole Pill + Budesonide+Formoterol inhaler, Lopinavir/Ritonavir + hydoxychloroquine - COVID-19
Phase 2 / Phase 3UnknownFasa University of Medical Sciences302020-04-042020-04-13
A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia
rabbit ATG, Cyclosporine, Levamisole - Aplastic Anemia
Phase 2CompletedInstitute of Hematology & Blood Diseases Hospital, China402014-08-012026-02-11
Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)
Levamisole+cyclosporin A+Glucocorticoids, cyclosporin A+Glucocorticoids, Glucocorticoids - Paroxysmal Nocturnal Hemoglobinuria, Hemoglobinuria
Phase 2UnknownInstitute of Hematology & Blood Diseases Hospital, China502013-01-012013-01-03
Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria
Levamisole+cyclosporin A+Glucocorticoids, cyclosporin A+Glucocorticoids, Glucocorticoids - Paroxysmal Nocturnal Hemoglobinuria, Hemoglobinuria
Phase 2UnknownInstitute of Hematology & Blood Diseases Hospital, China1202012-07-012013-01-03
Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.
levamisole, Prednisone - Anemia, Anemia, Hemolytic
Phase 2UnknownInstitute of Hematology & Blood Diseases Hospital, China1002012-04-012012-04-19
Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne
Levamisole - Acne
Phase 2 / Phase 3CompletedAhvaz Jundishapur University of Medical Sciences1692008-11-012011-05-05
Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients
Levamisole, Placebo - Renal Dialysis
Phase 2CompletedShiraz University of Medical Sciences402008-03-012013-07-26

Conditions studied

Anemia (3)  ·  Anemia, Aplastic (3)  ·  Anemia, Hemolytic (3)  ·  Hematologic Diseases (3)  ·  Bone Marrow Failure Disorders (2)  ·  Hemoglobinuria (2)  ·  Hemoglobinuria, Paroxysmal (2)  ·  Loiasis (2)  ·  Proteinuria (2)  ·  Thrombosis (2)  ·  Urination Disorders (2)  ·  Acne Vulgaris (1)  ·  Anemia, Hemolytic, Autoimmune (1)  ·  Autoimmune Diseases (1)  ·  COVID-19 (1)

Sponsors

Institute of Hematology & Blood Diseases Hospital, China (4)  ·  Programme National de Lutte contre l'Onchocercose, Republic of the Congo (2)  ·  Ahvaz Jundishapur University of Medical Sciences (1)  ·  Fasa University of Medical Sciences (1)  ·  Shiraz University of Medical Sciences (1)  ·  Vanderbilt University Medical Center (1)

Countries

China (4)  ·  Iran (3)  ·  Republic of the Congo (2)  ·  United States (1)

Top investigators

Mohamad Mahdi Sagheb, MD (1)  ·  Siamack Afazeli (1)  ·  Sima Rasaii, Dermtologist (1)  ·  Stephan Heckers, MD (1)  ·  Yizhou Zheng, doctor (1)  ·  Zheng Yizhou, M.D., Ph.D (1)

Results publications

PMID 1090310, PMID 12622583, PMID 18720689, PMID 23547851, PMID 24341659, PMID 32738928, PMID 34651190, PMID 40615414